ATE409707T1 - Chemotaktisches protein für granulozyten - Google Patents

Chemotaktisches protein für granulozyten

Info

Publication number
ATE409707T1
ATE409707T1 AT94901896T AT94901896T ATE409707T1 AT E409707 T1 ATE409707 T1 AT E409707T1 AT 94901896 T AT94901896 T AT 94901896T AT 94901896 T AT94901896 T AT 94901896T AT E409707 T1 ATE409707 T1 AT E409707T1
Authority
AT
Austria
Prior art keywords
pct
gcp
date
chemotactic protein
mammalian
Prior art date
Application number
AT94901896T
Other languages
English (en)
Inventor
Damme Jo Van
Paul Proost
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Lab filed Critical Serono Lab
Application granted granted Critical
Publication of ATE409707T1 publication Critical patent/ATE409707T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94901896T 1992-11-27 1993-11-26 Chemotaktisches protein für granulozyten ATE409707T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US98253992A 1992-11-27 1992-11-27

Publications (1)

Publication Number Publication Date
ATE409707T1 true ATE409707T1 (de) 2008-10-15

Family

ID=25529269

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94901896T ATE409707T1 (de) 1992-11-27 1993-11-26 Chemotaktisches protein für granulozyten

Country Status (6)

Country Link
US (1) US5840524A (de)
EP (1) EP0804486B1 (de)
AT (1) ATE409707T1 (de)
AU (1) AU5628394A (de)
DE (1) DE69334242D1 (de)
WO (1) WO1994012537A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5877276A (en) * 1994-09-23 1999-03-02 The Board Of Regents Of The University Of Nebraska Polypeptide agonists for human interleukin-8
US6139832A (en) * 1995-02-08 2000-10-31 Human Genome Sciences, Inc. Leukocyte adhesion inhibitor-1 (LAI-1) Polypeptides
US6410268B1 (en) 1996-03-18 2002-06-25 Human Genome Sciences, Inc. Polynucleotides encoding chemokine alpha-3
WO1997035027A1 (en) * 1996-03-18 1997-09-25 Human Genome Sciences, Inc. Chemokine alpha 3
JP2000507101A (ja) 1996-03-19 2000-06-13 ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド ケモカインアルファ２
AU4266197A (en) * 1996-09-12 1998-04-02 Incyte Pharmaceuticals, Inc. Granulocyte chemotactic protein 2 variant
EP0951549A1 (de) * 1996-10-02 1999-10-27 Schering Corporation Chemokine aus säugetieren
CA2267131A1 (en) * 1996-10-04 1998-04-09 Human Genome Sciences, Inc. Therapeutic compositions and methods for treating disease states with leukocyte adhesion inhibitor-1 (lai-1), and chemokine beta-11 (ck.beta.-11)
US7393696B2 (en) 2001-09-28 2008-07-01 Aspenbio Pharma, Inc. Bovine pregnancy test
EP1312614A1 (de) * 2001-11-16 2003-05-21 GenOdyssee Polynukleotide und Polypeptide des GCP-2 Gens
NZ572488A (en) 2002-05-02 2009-10-30 Univ Wyoming Pregnancy detection
CA2533124C (en) * 2003-08-12 2014-01-28 Tigenix N.V. Use of cxcl6 chemokine in the prevention or repair of cartilage defects
EP2021475B1 (de) * 2006-05-16 2011-10-26 University of Saskatchewan Hochaffine antagonisten von elr-cxc-chemokinen
WO2010070394A1 (en) * 2008-12-17 2010-06-24 Universite Pierre Et Marie Curie-Paris Vi Modulators of the cx3cr1 receptor and therapeutic uses thereof
GB202214951D0 (en) * 2022-10-11 2022-11-23 Univ London Queen Mary CXC receptor ligands

Also Published As

Publication number Publication date
EP0804486B1 (de) 2008-10-01
US5840524A (en) 1998-11-24
WO1994012537A3 (en) 1994-07-21
WO1994012537A2 (en) 1994-06-09
AU5628394A (en) 1994-06-22
EP0804486A2 (de) 1997-11-05
DE69334242D1 (de) 2008-11-13

Similar Documents

Publication Publication Date Title
DE69334242D1 (de) Chemotaktisches protein für granulozyten
Geisler et al. Amino acid sequence data on glial fibrillary acidic protein (GFA); implications for the subdivision of intermediate filaments into epithelial and non‐epithelial members.
EP1591529A3 (de) Humanes CLTA-8 und Verwendung von CLTA-8 ähnlichen Proteinen
DK82893D0 (da) Peptid
NL300153I1 (nl) Voor Factor VIIIC coderende DNA-sequenties en verwante DNA-constructen.
DE69326064D1 (de) Peptide des menschlichen Proteins P53 zum Gebrauch in menschlichen-zytotoxischen-T-Zell-Antwort-induzierenden Kompositionen sowie menschliche P53-Protein-spezifische T-Lymphocyten
DE59507920D1 (de) NEUE hIL-4-MUTANTENPROTEINE ALS ANTAGONISTEN ODER PARTIELLE AGONISTEN DES HUMANEN INTERLEUKIN 4
EA200000311A1 (ru) Новый белок иммунной системы - кау
ATE172743T1 (de) Nachweis von kollagenabbau -i(in vivo)
ATE213639T1 (de) Proteinreinigung
ATE275343T1 (de) Verarbeitung von pflantzlichem material mit xylanase
FI904951A0 (fi) Vaevnadsplasminogenaktivatorderivat.
Beresford et al. A role for heat shock protein 27 in CTL-mediated cell death
BR9407512A (pt) Sequência de ácidos nucléicos vírus recombinante defectivo vetor notadamente virale composição farmaceutica e utilização de uma sequencia de ácidos nucléicos
Mattick et al. The architecture of the animal fatty acid synthetase. II. Separation of the core and thioesterase functions and determination of the NC orientation of the subunit.
Kulkarni et al. Fibronectin binding and proteolytic degradation by Leishmania and effects on macrophage activation
NO982715L (no) Endotel celle-proliferasjonsinhibitor og fremgangsmate for anvendelse
ATE178072T1 (de) Neuartige polypeptide und ihre verwendung
BR9510067A (pt) Peptídio capaz de interagir com o domínio sh3 da proteína gap anticorpo ou fragmento de anticorpo dirigido contra um polipeptídeo sequência nucleotídica codificando para um polipeptídio ácido nucléico anti-sentido capaz de inibir ao menos parcialmente a produção de polipeptídeos sua utilização composição farmacêutica e utilização de um anticorpo ou fragmento de anticorpo
DK0486572T3 (da) Forbedringer i granulocyt-makrofag-kolonistimulerende faktorreceptor og derivater deraf
Prasad et al. Amino acid sequence of rat. alpha.-lactalbumin: a unique. alpha.-lactalbumin
ATE190318T1 (de) Pcna bindende substanz
DE69333952D1 (de) Klonering von dem gen für das t gondii protein gp 28.5 peptidfragmente aus diesem protein und ihre verwendungen.
DK0580672T3 (da) Syntetisk CDw52-(CAMPATH-1)-peptidantigen
Hensbergen et al. Processing of natural and recombinant CXCR3‐targeting chemokines and implications for biological activity

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties